Updated

A Yahoo Finance analysis examined whether Intuitive Surgical's stock valuation, often viewed as expensive, is actually justified given the company's growth profile and market position in robotic surgery systems. The piece weighs traditional valuation metrics against the company's competitive moat and growth trajectory. The analysis comes amid broader investor debate over how to value high-growth medical technology companies trading at premium multiples relative to the broader healthcare sector.